Doliracetam is a nootropic drug belonging to the racetam family, primarily used in the treatment of epilepsy. It is noted for its neuroanabolic properties, as indicated in the Hoechst patent.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | Doliracetam [INN], N70177JQTB, 2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide |
|---|---|
| IUPAC Name | 2-(2-oxo-3-phenyl-3H-indol-1-yl)acetamide |
| CAS | 84901-45-1 |
| Molecular Weight | 266.29 |
| Molecular Formula | C16H14N2O2 |
| SMILES | C1=CC=C(C=C1)C2C3=CC=CC=C3N(C2=O)CC(=O)N |